Search filters

List of works by Peter Lindgren

A Cluster-Randomized Controlled Trial Evaluating the Effectiveness and Cost-Effectiveness of Tobacco Cessation on Prescription in Swedish Primary Health Care: A Protocol of the Motivation 2 Quit (M2Q) Study

scientific article published on 16 September 2016

A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies.

scientific article

An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom

scientific article published on 29 January 2009

Association between achieving treatment goals for lipid-lowering and cardiovascular events in real clinical practice

scientific article published on 01 December 2005

Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research

scientific article published on 25 June 2020

Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Pol

scientific article published in June 2009

Compliance to Care Guidelines for Duchenne Muscular Dystrophy

scientific article published on January 2015

Compliance to care guidelines for Duchenne muscular dystrophy in Italy

scientific article published on 23 September 2016

Corrigendum to "Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)" [Neuromuscular Disorders 25 (2015) 937-944].

scientific article published on 14 March 2016

Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode

scientific article published on June 1, 2012

Cost of Parkinson's disease in Europe

scientific article published on 01 June 2005

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland

scientific article published on 03 May 2012

Cost-effectiveness analysis of exemestane compared with megestrol in advanced breast cancer: a model for Europe and Australia

scientific article published in January 2002

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.

scientific article

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

scientific article published in February 2005

Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial

scientific article published in May 2004

Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials

scientific article published on June 2007

Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials

scientific article published on 10 June 2008

Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland.

scientific article published on 06 July 2012

Cost-effectiveness of dronedarone in patients with atrial fibrillation in the ATHENA trial

scientific article published on 24 April 2013

Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin

scientific article published on 19 March 2007

Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice

scientific article published on 01 April 2003

Cost-effectiveness of statins revisited: lessons learned about the value of innovation

scientific article published on 29 April 2011

Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data

scientific article

Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis

scientific article published on 01 September 2006

Costs and quality of life in multiple sclerosis in The Netherlands

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in Austria

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in Germany.

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in Italy

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in Spain.

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in Sweden

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in Switzerland

scientific article published in September 2006

Costs and quality of life of multiple sclerosis in the United Kingdom

scientific article published in September 2006

Costs and quality of life of patients with multiple sclerosis in Europe

scientific article

Costs of Mini Mental State Examination-related cognitive impairment

scientific article published in October 1999

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation

scientific article published on 7 March 2008

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

scientific article published on 24 September 2020

Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry

scientific article published on 16 May 2015

Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugs

scientific article published on 01 August 2007

Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events

scientific article published on 26 October 2014

Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT).

scientific article published on 26 September 2015

Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis

scientific article published on 31 October 2016

Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic

scientific article

Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.

scientific article published on 4 October 2007

Economic evaluation of FE(NO) measurement in diagnosis and 1-year management of asthma in Germany

scientific article published on 29 October 2007

Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry.

scientific article published on 14 November 2013

Extreme Consumers of Health Care: Patterns of Care Utilization in Patients with Multiple Chronic Conditions Admitted to a Novel Integrated Clinic

scientific article published on 24 December 2019

Factors determining utility measured with the EQ-5D in patients with atrial fibrillation

scientific article published on 28 January 2010

From 4S to IDEAL: the health economics of the statin trials

scientific article published on April 2009

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

article published 13 June 2006 in European Heart Journal

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

article published 1 June 2007 in European Heart Journal Supplements

Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failure

scientific article

Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study

scientific article published on 19 October 2015

Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy

article

Introducing PIONEER: a project to harness big data in prostate cancer research

scientific article published on 27 May 2020

Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective

article by Peter Lindgren et al published April 2007 in International Journal of Technology Assessment in Health Care

Long term health care consumption and cost expenditure in systolic heart failure

scientific article published on 24 December 2012

Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany

scientific article (publication date: March 2007)

Managerial strategies to make incentives meaningful and motivating

scientific article published on April 2017

Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder.

scientific article published on 24 May 2011

Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden

scientific article published on 01 June 2008

Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden

scientific article

Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis

scientific article published in September 2002

Modelling the costs and effects of leflunomide in rheumatoid arthritis

scientific article published in January 2002

Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis

scientific article published on 14 June 2005

Patient Preferences for Treatments of Neuromuscular Diseases: A Systematic Literature Review

scientific article published on 8 November 2017

Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries

scientific article published on 7 September 2010

Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study

scientific article published in October 2008

Professionals' perspectives on a market-inspired policy reform: A guiding light to the blind spots of measurement

scientific article published on January 2017

Psychometric analysis of the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module administered to patients with Duchenne muscular dystrophy: A Rasch analysis

scientific article published on 21 February 2018

Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis

scientific article

Quantifying the burden of caregiving in Duchenne muscular dystrophy

scientific article published on 10 March 2016

Reduced work absenteeism in patients with hepatitis C treated with second-generation direct-acting antivirals

scientific article published on 08 September 2020

Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data

scientific article

Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS).

scientific article published in July 2009

Risk sharing in managed entry agreements-A review of the Swedish experience

scientific article published on 18 February 2020

Something borrowed, something new: measuring hospital performance in the context of value based health care

scientific article published on 16 June 2020

The burden of Duchenne muscular dystrophy: an international, cross-sectional study

scientific article

The cost and burden of cancer in the European Union 1995-2014.

scientific article

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model

scientific article published in July 1999

The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trial

scientific article (publication date: December 2005)

The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden

scientific article published in January 2003

The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study

scientific article published in December 2004

The development and validation of a scale to explore staff experience of governance of economic efficiency and quality (GOV-EQ) of health care

scholarly article by Sara Korlén et al published 12 December 2018 in BMC Health Services Research

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial

scientific article published on 24 May 2010

The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden

scientific article published on October 2009

The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.

scientific article

The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions

scientific article published on 21 April 2009

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden

scientific article (publication date: 2005)

The value of early treatment in patients with haemophilia and inhibitors.

scientific article published on 18 January 2010

Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden

scientific article published on 18 November 2015

Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes

scientific article published on 28 March 2010

Utility loss and indirect costs after stroke in Sweden

scientific article published in April 2008

Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy

scientific article published on March 2007

Paulina is supported by:

About Paulina

Help